Literature DB >> 3814302

Grading ovarian tumors. Evaluation of decision making by different pathologists.

J P Baak, J F Delemarre, F A Langley, A Talerman.   

Abstract

Although grading of ovarian tumors is widely performed, the criteria for each grade are not well defined; as a result, pathologists tend to establish their own criteria without, however, assessing the actual predictive value of the criteria. In order to investigate this relationship, four gynecologic pathologists independently reviewed and carefully graded as benign, borderline or malignant (grade I, II or III) 40 "common" epithelial tumors of the ovary, without reference to clinical, prognostic or other findings. Intermediate grades were allowed. Subsequently, a subjective grading form was completed for each case; the form contained questions regarding the histologic and cytologic features. The sets of features with the biggest correlation with the tumor grades differed among the pathologists. This may indicate that the observers use different features in their grading processes. Moreover, the pathologist with the highest number (five) of significant microscopic features in the multivariate model had the lowest coefficient of correlation between his tumor grade and his feature set. The correlation coefficients for the other pathologists were quite similar, although the features used (no more than two or three) varied. The participants in the study felt that the methodologic approach had an educational value for them. Further investigations are required to evaluate whether the differences in the underlying decision making process also result in frank disagreement in ovarian tumor grading.

Entities:  

Mesh:

Year:  1986        PMID: 3814302

Source DB:  PubMed          Journal:  Anal Quant Cytol Histol        ISSN: 0884-6812            Impact factor:   0.302


  3 in total

1.  NGS-based BRCA1/2 mutation testing of high-grade serous ovarian cancer tissue: results and conclusions of the first international round robin trial.

Authors:  Volker Endris; Albrecht Stenzinger; Nicole Pfarr; Roland Penzel; Markus Möbs; Dido Lenze; Silvia Darb-Esfahani; Michael Hummel; Andreas Jung; Ulrich Lehmann; Hans Kreipe; Thomas Kirchner; Reinhard Büttner; Wolfram Jochum; Gerald Höfler; Manfred Dietel; Wilko Weichert; Peter Schirmacher
Journal:  Virchows Arch       Date:  2016-03-22       Impact factor: 4.064

2.  Long-term survival of young women receiving fertility-sparing surgery for ovarian cancer in comparison with those undergoing radical surgery.

Authors:  H Kajiyama; K Shibata; M Mizuno; T Umezu; S Suzuki; A Nawa; M Kawai; T Nagasaka; F Kikkawa
Journal:  Br J Cancer       Date:  2011-10-04       Impact factor: 7.640

3.  The transcriptomic profile of ovarian cancer grading.

Authors:  Cindy Q Yao; Francis Nguyen; Syed Haider; Maud H W Starmans; Philippe Lambin; Paul C Boutros
Journal:  Cancer Med       Date:  2014-10-15       Impact factor: 4.452

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.